Atai Life Sciences N.V.
ATAI
$4.83
$0.091.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.73M | -26.43M | -38.96M | -26.29M | -57.31M |
| Total Depreciation and Amortization | 227.00K | 216.00K | 225.00K | 83.00K | 82.00K |
| Total Amortization of Deferred Charges | 27.00K | 149.00K | 188.00K | 131.00K | 98.00K |
| Total Other Non-Cash Items | 5.58M | 9.95M | 18.29M | 9.76M | 38.02M |
| Change in Net Operating Assets | 7.80M | -1.73M | -4.04M | -3.03M | 2.88M |
| Cash from Operations | -14.09M | -17.84M | -24.30M | -19.34M | -16.23M |
| Capital Expenditure | -127.00K | -1.02M | -6.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 359.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.91M | -10.00M | 6.21M | 24.84M | 16.30M |
| Cash from Investing | 9.78M | -11.01M | 6.56M | 24.84M | 16.30M |
| Total Debt Issued | -- | -- | 0.00 | 5.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.62M | 60.17M | 154.00K | 55.00K | 326.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.87M | -564.00K | 0.00 | -161.00K | -- |
| Cash from Financing | 7.76M | 59.61M | 154.00K | 4.89M | 326.00K |
| Foreign Exchange rate Adjustments | 206.00K | 32.00K | 123.00K | 237.00K | 66.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 1.00K |
| Net Change in Cash | 3.65M | 30.78M | -17.46M | 10.63M | 466.00K |